Peritonsillar Abscess: Structured Management with Drainage and Broad-Spectrum IV Antibiotics
Peritonsillar abscess requires timely, structured management. The protocol pairs abscess drainage with antibiotic therapy and supportive measures, using defined clinical milestones to guide readiness for discharge.
Clinical Goals
The patient should be able to tolerate oral intake, breathe without respiratory distress, not be septic, and have no active bleeding.
Treatment Overview
Management combines abscess drainage with broad-spectrum IV antibiotic therapy — selected to address the polymicrobial flora characteristic of PTAs — together with IV fluid rehydration and adjunctive agents. The complete antibiotic regimen options, drainage approach selection, and step-down oral course are specified in the full protocol.
References
- However, broad-spectrum antibiotics are often utilized as first-line therapy given the polymicrobial composition and rates of penicillin-resistant organisms of PTAs (Galioto 2017).
- The use of steroids in the management of PTA continues to be debated but some evidence seems to support that adjunctive, high-dose, short-term use is safe and beneficial (Kent et al., 2019).
- Often discharge home after drainage/tonsillectomy if patient can drink, is breathing well, not septic, and is not actively bleeding.